A Systematic Review on Disease‐Drug‐Drug Interactions with immunomodulating drugs: A Critical Appraisal of Risk Assessment and Drug Labelling - Jong - - British Journal of Clinical Pharmacology - Wiley Online Library
This systematic analysis aimed to characterize the available DDDI trials with immunomodulatory drugs, experimental evidence for a DDDI risk, and reported DDDI risk information in FDA/EMA approved drug labelling. To read the full article, log in using your NHS OpenAthens details.
